Bristol Myers Squibb Co. (BMY), And Talk Of Dividend Yields In Pharma

Page 1 of 2

As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares. But by sticking with quality – and with companies that are keeping their product pipelines full with new drugs – one can certainly find the key to not just share growth but also a nice steady income along the way.

Keeping yields healthy

Bristol Myers Squibb Co. (NYSE:BMY)One of the higher yielding big pharmaceutical companies, GlaxoSmithKline plc (ADR) (NYSE:GSK), operates through three primary segments: consumer health care, vaccines, and pharmaceuticals. This UK-based powerhouse has continued to expand into emerging markets – especially capitalizing on the growth that is taking place in many developing-international economies – which is a likely factor in its positive financials.

One of the biggest focus areas for GlaxoSmithKline plc (ADR) (NYSE:GSK) has been with its GLP-1 agonists. This medication for patients who are suffering from diabetes claims to offer less risk to its users than some of the other related types of medication that are currently available on the market today. GlaxoSmithKline plc (ADR) (NYSE:GSK) has also recently gained acceptance by the U.S. FDA for its fluticasone furoate, a COPD, or Chronic Obstructive Pulmonary Disease-management drug application.

Although analysts expect GlaxoSmithKline plc (ADR) (NYSE:GSK)’s share price to rise by only 3% over the next 12 months, the $2.76 per share dividend payout is yielding investors approximately 6% annually.

In keeping with healthy dividend yields, investors may also want to consider Eli Lilly & Co. (NYSE:LLY). Here, too, is a big pharma company that focuses on the development, manufacturing, and sale of drugs for both humans and animals. The span of Eli Lilly & Co. (NYSE:LLY)’s market encompasses the U.S. and roughly 130 additional countries.

This company also has a strong presence in the diabetes-management area with its investigational med Dulaglutide. Other medications that Eli Lilly & Co. (NYSE:LLY) currently has in clinical testing include a depression drug called Edivoxetine and a new insulin glargine product.

Eli Lilly & Co. (NYSE:LLY)’s recent announcement about an agreement it has entered into with Qiagen has been well received in the industry and by investors. This program will work in the area of development and commercialization of companion diagnostics with drugs across numerous therapeutic areas using both investigational meds and those that have already been approved for use.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!